scholarly journals Outcomes of Treatment with the Chimeric Antigen Receptor (CAR) T Cell Therapy Lisocabtagene Maraleucel (liso-cel) at Nonuniversity Medical Centers (NMCs): Initial Results from the Outreach Study in Patients with Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)

2021 ◽  
Vol 27 (3) ◽  
pp. S203-S204
Author(s):  
John Godwin ◽  
Cesar O. Freytes ◽  
Michael Maris ◽  
Don A. Stevens ◽  
Daanish Hoda ◽  
...  
Keyword(s):  
Cell Therapy ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
T Cell Therapy ◽  
Medical Centers ◽  
Large B Cell Lymphoma ◽  
Car T Cell Therapy ◽  
Car T ◽  
Initial Results ◽  
Large B Cell

scholarly journals Rapid relapse of large B‐cell lymphoma after CD19 directed CAR‐T‐cell therapy due to CD‐19 antigen loss

2019 ◽  
Vol 94 (10) ◽  
Author(s):  
Ali Bukhari ◽  
Firas El Chaer ◽  
Rima Koka ◽  
Zeba Singh ◽  
Elizabeth Hutnick ◽  
...  
Keyword(s):  
Cell Therapy ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
T Cell Therapy ◽  
Large B Cell Lymphoma ◽  
Car T Cell Therapy ◽  
Car T ◽  
Antigen Loss ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document